Amalia Lafuente Flo
CLINICAL AND PROVINCIAL HOSPITAL OF BARCELONA
Sant Pau Biomedical Research Institute
Spain
Biography
Amalia Lafuente Flo is a PhD in Medicine and Surgery, Full Professor of Pharmacology, University of Barcelona, ​​and researcher at the Biomedical Research Institute IDIBAPS and the Schizophrenia Clinic Program (PEC). In 1995 he worked as Research Associate at the University of Berkeley, and is a stable collaborator with the Pharmacology group at Johns Hopkins University, USA. He has been Principal Investigator of more than twenty research projects dedicated to pharmacogenetics, which have resulted in several publications in international journals and a dozen doctoral theses directed. She is currently responsible for the Pharmacology Unit of the Faculty of Medicine and is responsible for the Genetic Area of ​​the Schizophrenia Clinic Group (GEC) included in the recently constituted CIBER-sam.
Research Interest
Medicine and Surgery, Pharmacology
Publications
-
Anna Crescenti, Patricia Gassó, Jose M Vidal-Taboada, Amalia Lafue. DNA Cards: Determinants of DNA Yield and Quality in Collecting Genetic Samples for Pharmacogenetic Studies. Volume 101, Issue 2 August 2007 Pages 132–137.
-
S Mas1,2,3, P Gassó1,2,3, D Boloc1, N Rodriguez1, F Mármol1, J Sánchez1, M Bernardo2,3,4,5 and A Lafuente1,2,3. Network analysis of gene expression in mice provides new evidence of involvement of the mTOR pathway in antipsychotic-induced extrapyramidal symptoms. The Pharmacogenomics Journal (2016) 16, 293–300
-
Lafuente A1, Bernardo M, Mas S, Crescenti A, Aparici M, Gasso P, Deulofeu R, Mane A, Catalan R, Carne X. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders. Psychiatry Res. 2008 Nov 30;161(2):131-41.
